nach oben

Erschienen in:

01.07.2010 | Clinical study

Sibutramine: 'real-life' study shows it's not so bad after all

Erschienen in: Reactions Weekly | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Excerpt

According to a postmarketing study conducted in the New Zealand general population, the risk of death from cardiovascular events in patients prescribed sibutramine is lower than in other overweight/obese populations.1 …

Harrison-Woolrych M, Ashton J, Herbison P.Fatal and non-fatal cardiovascular events in a general population prescribed sibutramine in New Zealand: a prospective cohort study. Drug Safety 33: 605-613, No. 7, 2010

Scheen AJ.Controversy about the cardiovascular safety of sibutramine. Drug Safety 33: 615-518, No. 7, 2010

Titel: Sibutramine: 'real-life' study shows it's not so bad after all
Publikationsdatum: 01.07.2010
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2010
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-201013110-00006

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Anticholinergics carry increased risk of constipation

Vincristine

Rocuronium bromide

Gugua

Colecalciferol

Risperidone